循環器リズムバイオマーカーと歩行式血圧モニタリングの関連性と急性不全性脳卒中患者の予後と結果:症例対照研究
Virendra Atam1, Nikhil K Gupta1, Manohar K Jha1
1Internal Medicine, King George's Medical University, Lucknow, IND.
Cureus
|September 3, 2025
まとめ
メラトニンが低下し,血圧パターンが変化することで特徴づけられる循環器リズム障害は,急性不全性脳卒中 (AIS) の患者でより悪い結果と関連しています. これらのバイオマーカーは 脳卒中の重度や回復を予測します
科学分野:
- 神経科学
- 内分泌学
- 心臓病科
背景:
- 生理学的調節に重要な役割を果たしています.
- コルチゾールやメラトニンのような サーカディアンバイオマーカーの乱れは 様々な健康状態に関係しています
- 急性不全性脳卒中 (AIS) のこれらの障害を理解することは,予後のために不可欠です.
研究 の 目的:
- 唾液中のコルチゾールと尿中のメラトニン濃度と,AIS患者における出院式血圧モニタリング (ABPM) パターンの関連性を調査する.
- 脳卒中の重度や 機能的な結果を予測できるかどうかを判断する.
主な方法:
- 75人のAIS患者と75人の対照群を対象としたケース・コントロール研究.
- ELISAを用いた唾液コルチゾールと尿メラトニンの測定
- 24時間循環式血圧モニタリング (ABPM)
- 脳卒中の重症度 (NIHSS) と機能的アウトカム (MRS) の評価
主要な成果:
- AIS患者の尿中のメラトニン濃度は,対照群と比較して有意に低下した.
- AIS患者では非浸入型および逆浸入型ABPMの有病率が高かった.
- メラトニンのレベルが低いと 脳卒中の重度や障害のスコアが高いと強く相関しています
- コルチゾールのレベルが上昇すると 脳卒中の重症度が上がるのです
結論:
- シルカディアンバイオマーカーの変化 (メラトニンの減少,コルチゾールの上昇) は,脳卒中の重度増加とAISにおける機能的アウトカムが悪化するとの関連がある.
- 異常なABPMパターンは,脳卒中の予後に関連した自律的失調を示唆します.
- シルカディアンバイオマーカーは脳卒中の回復を予測し,治療目標を特定する可能性を秘めています.
関連する概念動画
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
123
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
123
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Errors occurring during blood pressure monitoring
964
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
964
Pre-Procedural Guidelines for Assessing Blood Pressure
626
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
626


